Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Delgocitinib in Early-Stage Cutaneous T-Cell Lymphoma
NCT07781449Phase 2Not yet recruiting
- Sponsor
- Aarhus University Hospital
- Start
- Sep 2026
- Primary completion
- Jun 2028
01
Overview
A Phase 2 trial of delgocitinib in mycosis fungoides (MF), sponsored by Aarhus University Hospital. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
delgocitinib
03
Conditions
mycosis fungoides (MF)
Beyond the preview
Go deeper on NCT07781449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07781449.